Organization · Private Equity

Harwood Private Equity LLP

Harwood Private Equity LLP is a private equity firm based in Mayfair, London, specializing in investments in UK lower mid-market companies. The firm focuses on buyouts and public-to-private transactions, targeting profitable businesses across various sectors.

Private EquityFunder

Overview

What Harwood Private Equity LLP does

What Harwood Private Equity LLP is

Harwood Private Equity LLP is a private equity firm based in Mayfair, London, specializing in investments in UK lower mid-market companies. The firm focuses on buyouts and public-to-private transactions, targeting profitable businesses across various sectors.

How it participates in the startup ecosystem

The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Private Equity
Founded
Founded in 1999
Approximate age
About 27 years
Structured capabilities
Funder
Last reviewed
March 27, 2026

Official channels

Find Harwood Private Equity LLP elsewhere

Open the official website or a supported primary organization account.

Capability profile

Harwood Private Equity LLP as a funder

Investment thesis

Harwood Private Equity LLP focuses on investing in small and medium-sized enterprises in the UK lower mid-market, employing a low-leverage strategy to unlock value in promising private businesses and undervalued quoted companies.

Focus narrative

Harwood Private Equity invests in UK small and medium-sized companies with an enterprise value between £15 million and £75 million. The firm targets a diverse range of sectors, including life sciences, biotechnology, multi-site leisure, precision manufacturing, financial services, media, and healthcare components and services. The investment strategy emphasizes management buyouts, expansion capital, and public-to-private transactions, with a historical completion rate of two to four acquisitions per year.

Value beyond capital

Harwood Private Equity adds value through its expertise in management buyouts and public-to-private transactions, leveraging a low-leverage strategy to enhance the growth potential of its portfolio companies.

Terms and economics

Typical check
$18,500,000–$93,000,000

Focus and fit

Stages
Series A · Series B · Growth Equity

Availability

Currently deploying
Yes

Portfolio and track record

Recorded portfolio count
12
Recorded notable exits
APC Technology Group

Portfolio context

Harwood Private Equity has invested a total of £731 million across 67 companies since its inception. Notable current investments include Tissue Regenix, a provider of regenerative medicine products; Crest Foods; Source BioScience; SMT Corporation; Fothergill’s; WaterBox; 3BL Media; and Medica Packaging.

Connected ecosystem

Continue from Harwood Private Equity LLP

These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.

Common questions

What to know about Harwood Private Equity LLP

Upseed classifies Harwood Private Equity LLP under the Private Equity organization type. Its current public profile includes funder capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

March 27, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.